Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH has floated a tender for Qiagen LLC Reagents and Consumables. The project location is USA and the tender is closing on 11 Oct 2024. The tender notice number is NIH-CC-OPC-25-000149, while the TOT Ref Number is 108082771. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Qiagen LLC Reagents and Consumables
Deadline : 11 Oct 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 108082771
Document Ref. No. : NIH-CC-OPC-25-000149
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institute of Health/Clinical Center/Office of Purchasing and Contracts intends to award a firm fixed price contract to Qiagen LLC, Germantown, MD 20874 for reagent kits and consumables.
Qiagen LLC is the only vendor/manufacturer that can provide the reagent kits and consumables used to isolate DNA and RNA from various cell populations from peripheral blood of stem cell transplant patients or patients with hematological disorder and are specifically used with already existing instrumentation within The Department of Laboratory Medicine of the Clinical Center. The testing done using these reagents is for basic clinical care, research, and advancing the science and applications associated with diagnostic analysis of hematological disorders such as Myeloproliferative diseases and Chimerism monitoring after Allogenic Stem Cell transplant. These reagents have been fully validated for use in BCR-ABL fusion assay and JAK2 mutation assay. Switching to another system would entail lengthy validations and would alter current results of NIH protocols.
The estimated product list is attached to this notice and titled - Attachment 1 - List of Supplies 25-000149. The government reserves the right to increase quantities pursuant to FAR 52.217-6.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1). For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting o icer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Int...
Active Contract Opportunity
Notice ID : NIH-CC-OPC-25-000149
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH - CC
General Information
Contract Opportunity Type: Presolicitation (Original)
Original Published Date: Oct 02, 2024 12:53 pm EDT
Original Response Date: Oct 11, 2024 12:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 26, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Bethesda, MD 20892 USA
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google